Product Images Foscarnet Sodium
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Foscarnet Sodium NDC 0143-9192 by Hikma Pharmaceuticals Usa Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This description is for a medication called Foscarnet Sodium, USP, which is administered via intravenous infusion. Each mL of the solution contains 24 mg of Foscarnet Sodium and is adjusted to a pH of 7.4. The solution is sterile, non-pyrogenic, and should be stored between 20°C and 25°C. It must be protected from excessive heat and freezing. The recommended administration method is via controlled intravenous infusion at a specified rate. The dosage information can be found in the package insert. It also provides precautions for administering via a peripheral vein catheter. This medication is for single-dose use and any unused portion should be discarded.*
The text provides information about Foscarnet Sodium Injection, a sterile and non-pyrogenic solution used for intravenous infusion. It contains 24g of Foscarnet Sodium and is administered by controlled intravenous infusion. The dosage, administration precautions, storage instructions, and manufacturer details are also mentioned. The solution is intended for central intravenous infusion and should be diluted for peripheral intravenous infusion. It is essential to ensure bottle and seal integrity before use. The text also includes precise dosing information and cautions regarding the administration process.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.